Angiotensin II signaling and HB-EGF shedding via metalloproteinase in glomerular mesangial cells.

BACKGROUND Angiotensin II (Ang II) has been implicated in the development of glomerulosclerosis by stimulating fibronectin (FN) synthesis. The processing and release of heparin binding-endothelin growth factor (HB-EGF) are activated by protein kinase C (PKC) and Ca2+ signaling. We studied the roles of HB-EGF and endothelial growth factor (EGF) receptor (EGFR) in Ang II-induced FN expression using mesangial cells. METHODS Mesangial cells were prepared from mouse kidneys by the explant method and cells were used at passages 4 and 5. RESULTS Ang II stimulated FN mRNA levels dose-dependently with a maximal increase (3.4-fold) after 12 hours of incubation. This action was completely inhibited by PKC inhibitors and slightly blocked by Ca2+ chelating agents. FN mRNA accumulation by Ang II was abolished by tyrosine kinase inhibitors, a specific inhibitor for EGFR (AG1478) and extracellular signal-regulated kinase (ERK) inactivation. Addition of neutralizing anti-HB-EGF antibody, as well as pretreatment with heparin or the metalloproteinase inhibitor batimastat abolished induction of FN expression by Ang II. In mesangial cells stably transfected with a chimeric construct containing HB-EGF and alkaline phosphatase (ALP) genes, ALP activity in incubation medium was rapidly increased by Ang II (1.7-fold at 0.5 min) and reached a 4.1-fold increase at two minutes. Ang II phosphorylated EGFR (maximal at 2 min) and ERK (maximal at 8 min) in a PKC- and metalloproteinase-dependent manner. Ang II stimulated the expression and release of transforming growth factor-beta (TGF-beta) via EGFR-mediated signaling, and the released TGF-beta also contributed to Ang II-mediated FN expression via EGFR transactivation. CONCLUSIONS Ang II-mediated FN expression was regulated by autocrine effects of HB-EGF and TGF-beta, suggesting a novel paradigm for cross-talk between Ang II and growth factor receptor signaling pathways.

[1]  S Eguchi,et al.  Activation of MAPKs by Angiotensin II in Vascular Smooth Muscle Cells , 2001, The Journal of Biological Chemistry.

[2]  Y. Matsuzawa,et al.  Ectodomain Shedding of Epidermal Growth Factor Receptor Ligands Is Required for Keratinocyte Migration in Cutaneous Wound Healing , 2000, The Journal of cell biology.

[3]  K. Bland,et al.  Estrogen-induced activation of Erk-1 and Erk-2 requires the G protein-coupled receptor homolog, GPR30, and occurs via trans-activation of the epidermal growth factor receptor through release of HB-EGF. , 2000, Molecular endocrinology.

[4]  Herbert J. Kramer,et al.  Angiotensin II-induced growth of vascular smooth muscle cells requires an Src-dependent activation of the epidermal growth factor receptor1 , 2000 .

[5]  R. Harris.  EGF receptor activation by G-protein coupled receptors. , 2000, Kidney international.

[6]  J. Abraham,et al.  Heparin blockade of thrombin-induced smooth muscle cell migration involves inhibition of epidermal growth factor (EGF) receptor transactivation by heparin-binding EGF-like growth factor. , 2000, Circulation research.

[7]  Y. Sun,et al.  Local angiotensin II and transforming growth factor-beta1 in renal fibrosis of rats. , 2000, Hypertension.

[8]  A. Sali,et al.  Genomics: Functional links between proteins , 1999, Nature.

[9]  A. Ullrich,et al.  The EGF receptor as central transducer of heterologous signalling systems. , 1999, Trends in pharmacological sciences.

[10]  Y. Mori,et al.  Angiotensin II type 2 receptor overexpression activates the vascular kinin system and causes vasodilation. , 1999, The Journal of clinical investigation.

[11]  Y. Mori,et al.  Angiotensin II-induced transactivation of epidermal growth factor receptor regulates fibronectin and transforming growth factor-beta synthesis via transcriptional and posttranscriptional mechanisms. , 1999, Circulation research.

[12]  R. Weiss,et al.  TGF-beta- and angiotensin-II-induced mesangial matrix protein secretion is mediated by protein kinase C. , 1998, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[13]  Y. Mori,et al.  Role of calcium-sensitive tyrosine kinase Pyk2/CAKbeta/RAFTK in angiotensin II induced Ras/ERK signaling. , 1998, Hypertension.

[14]  Y. Mori,et al.  Tissue-Specific Expression of Human Angiotensin II AT1 and AT2 Receptors and Cellular Localization of Subtype mRNAs in Adult Human Renal Cortex Using in situ Hybridization , 1998, Nephron.

[15]  M. Shibuya,et al.  Angiotensin II type 1 receptor-induced extracellular signal-regulated protein kinase activation is mediated by Ca2+/calmodulin-dependent transactivation of epidermal growth factor receptor. , 1998, Circulation research.

[16]  H. Kawakatsu,et al.  Calcium-dependent Epidermal Growth Factor Receptor Transactivation Mediates the Angiotensin II-induced Mitogen-activated Protein Kinase Activation in Vascular Smooth Muscle Cells* , 1998, The Journal of Biological Chemistry.

[17]  H. Matsubara,et al.  Molecular insights into angiotensin II type 1 and type 2 receptors: expression, signaling and physiological function and clinical application of its antagonists. , 1998, Endocrine journal.

[18]  M. Klagsbrun,et al.  Heparin-binding EGF-like growth factor. , 1997, Biochimica et biophysica acta.

[19]  Y. Mori,et al.  Angiotensin type 2 receptors are reexpressed by cardiac fibroblasts from failing myopathic hamster hearts and inhibit cell growth and fibrillar collagen metabolism. , 1997, Circulation.

[20]  M. Mukoyama,et al.  Growth-dependent induction of angiotensin II type 2 receptor in rat mesangial cells. , 1997, Hypertension.

[21]  A. Pollock,et al.  Gelatinase A is a glomerular mesangial cell growth and differentiation factor. , 1997, Kidney international.

[22]  B. Berk,et al.  Angiotensin II signal transduction in vascular smooth muscle: role of tyrosine kinases. , 1997, Circulation research.

[23]  S. Kudoh,et al.  Protein Kinase C, but Not Tyrosine Kinases or Ras, Plays a Critical Role in Angiotensin II-induced Activation of Raf-1 Kinase and Extracellular Signal-regulated Protein Kinases in Cardiac Myocytes* , 1996, The Journal of Biological Chemistry.

[24]  Y. Mori,et al.  Down-regulation by cAMP of angiotensin II type 2 receptor gene expression in PC12 cells. , 1996, Hypertension research : official journal of the Japanese Society of Hypertension.

[25]  M. Marrero,et al.  The Importance of Tyrosine Phosphorylation in Angiotensin II Signaling. , 1996, Trends in cardiovascular medicine.

[26]  S. Eguchi,et al.  Identification of an Essential Signaling Cascade for Mitogen-activated Protein Kinase Activation by Angiotensin II in Cultured Rat Vascular Smooth Muscle Cells , 1996, The Journal of Biological Chemistry.

[27]  A. Ullrich,et al.  Role of transactivation of the EGF receptor in signalling by G-protein-coupled receptors , 1996, Nature.

[28]  J. Sadoshima,et al.  The heterotrimeric G q protein‐coupled angiotensin II receptor activates p21 ras via the tyrosine kinase‐Shc‐Grb2‐Sos pathway in cardiac myocytes. , 1996, The EMBO journal.

[29]  A. Levitzki,et al.  Tyrosine kinase inhibition: an approach to drug development. , 1995, Science.

[30]  W. Stetler-Stevenson,et al.  Assessment of 72-kilodalton gelatinase and TIMP-1 gene expression in normal and sclerotic murine glomeruli. , 1994, Journal of the American Society of Nephrology : JASN.

[31]  H. Singer,et al.  Involvement of protein kianse C and Ca2+ in angiotensin II-induced mitogenesis of cardiac fibroblasts. , 1994, The American journal of physiology.

[32]  S. Yamada,et al.  Angiotensin II receptor subtypes in bovine and human ventricular myocardium. , 1994, The Journal of pharmacology and experimental therapeutics.

[33]  W. Schorb,et al.  Angiotensin II-induced protein tyrosine phosphorylation in neonatal rat cardiac fibroblasts. , 1994, The Journal of biological chemistry.

[34]  S. Kagami,et al.  Angiotensin II stimulates extracellular matrix protein synthesis through induction of transforming growth factor-beta expression in rat glomerular mesangial cells. , 1994, The Journal of clinical investigation.

[35]  H. Matsubara,et al.  Rat angiotensin II (type 1A) receptor mRNA regulation and subtype expression in myocardial growth and hypertrophy. , 1993, Circulation research.

[36]  M. Klagsbrun,et al.  Heparin-binding EGF-like growth factor stimulation of smooth muscle cell migration: dependence on interactions with cell surface heparan sulfate , 1993, The Journal of cell biology.

[37]  J. Herbert,et al.  Characterization of specific binding sites for [3H]-staurosporine on various protein kinases. , 1990, Biochemical and biophysical research communications.

[38]  T. Tamaoki,et al.  Calphostin C (UCN-1028C), a novel microbial compound, is a highly potent and specific inhibitor of protein kinase C. , 1989, Biochemical and biophysical research communications.

[39]  J. Seltzer,et al.  H-ras oncogene-transformed human bronchial epithelial cells (TBE-1) secrete a single metalloprotease capable of degrading basement membrane collagen. , 1988, The Journal of biological chemistry.

[40]  K. Catt,et al.  Localization of angiotensin II receptors in rat and monkey kidney by in vitro autoradiography. , 1987, Kidney international. Supplement.

[41]  J. Sadoshima,et al.  Angiotensin II and Other Hypertrophic Stimuli Mediated by G Protein–Coupled Receptors Activate Tyrosine Kinase, Mitogen-Activated Protein Kinase, and 90-kD S6 Kinase in Cardiac Myocytes The Critical Role of Ca2+-Dependent Signaling , 1995 .

[42]  H. Matsubara,et al.  Regulation of gene transcription of angiotensin II receptor subtypes in myocardial infarction. , 1995, The Journal of clinical investigation.

[43]  T. Inagami,et al.  Angiotensin II Receptor: Molecular Cloning, Functions, and Regulation , 1994 .

[44]  D. Lovett,et al.  Transforming growth factor-beta 1 stimulates glomerular mesangial cell synthesis of the 72-kd type IV collagenase. , 1994, The American journal of pathology.

[45]  R. Hynes,et al.  Molecular biology of fibronectin. , 1985, Annual review of cell biology.